CD274 and non-small cell lung carcinoma: First, the authors mentioned that “followed by the article published in Clinical Research, titled “Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade”.